SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-022227
Filing Date
2021-11-08
Accepted
2021-11-08 16:17:52
Documents
14
Period of Report
2021-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aveo-20211108.htm   iXBRL 8-K 36872
2 EX-99.1 aveo-2021930xexx991.htm EX-99.1 109067
6 aeo.jpg GRAPHIC 4922
  Complete submission text file 0001628280-21-022227.txt   299668

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aveo-20211108.xsd EX-101.SCH 1915
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aveo-20211108_lab.xml EX-101.LAB 22875
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aveo-20211108_pre.xml EX-101.PRE 11997
7 EXTRACTED XBRL INSTANCE DOCUMENT aveo-20211108_htm.xml XML 10892
Mailing Address 30 WINTER STREET BOSTON MA 02108
Business Address 30 WINTER STREET BOSTON MA 02108 857-400-0101
AVEO PHARMACEUTICALS, INC. (Filer) CIK: 0001325879 (see all company filings)

IRS No.: 043581650 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34655 | Film No.: 211388206
SIC: 2834 Pharmaceutical Preparations